¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Koko Peak Pro Adapter Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adapter
    1. ¿¬°á±â 2. À¯µµ°ü 3. ÀûÀÀ±â
  • peak
    ÃÖ°íÁ¡, ÃÖ´ë
  • peak concentration time
    ÃÖ°í³óµµ½Ã°£
  • peak expiratory flow
    Ãִ볯¼ûÀ¯·®
  • peak expiratory flow rate
    ÃÖ°í³¯¼ûÀ¯¼Ó, ÃÖ°íÈ£±âÀ¯¼Ó
  • peak flow meter
    ÃÖ´ëÀ¯·®°è, ÃÖ°íÀ¯·®°è
  • peak flow rate
    1. ÃÖ°íÀ¯¼Ó 2. ÃÖ°í¿äÈ帧¼Óµµ 3. ÃÖ´ëÀ¯·®
  • peak level
    ÃÖ°íÄ¡
  • peak metabolism
    ÃÖ´ë´ë»ç
  • sensory peak latency
    °¨°¢½Å°æÁ¤Á¡Àá½Ã
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • peak level
    ÃÖ°íÄ¡
  • peak
    ÃÖ°íÁ¡
  • peak expiratory flow rate
    ÃÖ°í³¯¼û¼Óµµ, ÃÖ°íÈ£±âÀ¯¼Ó
  • peak growth velocity
    Ãִ뼺Àå¼Óµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adapter
    (¢¡adaptor) ¿¬°á±â, À¯µµ°ü, ÀûÀÀ±â
  • peak expiratory flow
    Ãִ볯¼ûÀ¯·®
  • peak level
    ÃÖ°íÄ¡
  • sensory peak latency
    °¨°¢½Å°æÁ¤Á¡Àá½Ã
  • peak metabolism
    ÃÖ´ë´ë»ç
  • peak flow meter
    ÃÖ´ëÀ¯·®°è, ÃÖ°íÀ¯·®°è
  • peak
    ÃÖ°íÁ¡
  • peak concentration time
    ÃÖ°í³óµµ½Ã°£
  • peak expiratory flow rate
    ÃÖ°í³¯¼û·ù·®
  • peak flow rate
    ÃÖ°íÀ¯¼Ó, ÃÖ°í±â·ù·®
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â, ÃÖ°í±â¿ï±â¼¼±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • POMC(pro-opio-melano-cortin)
    Àü¾ÆÆí¾ç¸á¶ó´ÑÀÚ±ØÈ£¸£¸ó
  • adapter =adaptor
    ¿¬°á±â<°ü>, ÀûÀÀ±â, ¾Æ´ðÅÍ, Á¢ÇÕ±â.¼Ò¾ÆÀ¯µµ°ü.
  • adapter =adaptor
    ¿¬°á±â<°ü>, ÀûÀÀ±â, ¾Æ´ðÅÍ, Á¢ÇÕ±â.[¼Ò¾Æ]À¯µµ°ü.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adapter =adaptor
    ¿¬°á±â<°ü>, ÀûÀÀ±â, ¾Æ´ðÅÍ, Á¢ÇÕ±â.[¼Ò¾Æ]À¯µµ°ü.
  • adapter =adaptor
    ¿¬°á±â<°ü>, ÀûÀÀ±â, ¾Æ´ðÅÍ, Á¢ÇÕ±â.¼Ò¾ÆÀ¯µµ°ü.
  • external occipital protuberance<³ª> pro tube r antia occipitalis externa
    ¿ÜÈĵÎÀ¶±â(èâý­ÔéëØÑÃ).
  • gradient echo technique magnetic susceptibility pro
    °æ»ç ¿¡ÄÚ¹ý ÀÚ±âÈ­À² ¾ç¼ºÀÚ ÀÌ¿Ï Áõ°­
  • peer review organization(PRO)
    µ¿·á½É»çÀ§¿øÈ¸.
  • peak
    ÃÖ°íÁ¡
  • peak
    ÃÖ°íÁ¡(õÌÍÔïÇ), Á¤(ð¢).
  • peak absorbed dose
    ÃÖ´ëÈí¼ö¼±·®
  • peak concentration
    ÃÖ°í³óµµ(¡­ÒØöô).
  • peak concentration time
    ÃÖ°í³óµµ½Ã°£(õÌÍÔÒØöôãÁÊà).
  • peak expiratory flow
    ÃÖ´ëÈ£±âÀ¯·®.
  • peak expiratory flow rate
    ÃÖ°íÈ£±âÀ¯·®(õÌÍÔû¼Ñ¨êüåÖ).
  • peak flow meter
    ÃÖ´ëÀ¯·®°è, ÃÖ°íÀ¯·®°è (¡­êüåÖͪ).
  • peak flow rate
    ÃÖ´ëÀ¯¼Ó, ÃÖ°íÀ¯¼Ó(õÌÍÔ êüáÜ).
  • peak gradient strength
    ÃÖ°í °æ»ç ¼¼±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • air peak
    °ø±âÁ¤Á¡ (ÍöѨð¢ïÇ)
  • adapter RNA
    ¾Æ´äÅÍ RNA
  • adapter hypothesis
    ¾Æ´äÅͼ³(àã)
  • pro-
    ÇÁ·Î-
  • pro-ACTH-endorphin
    ÇÁ·Î-ACTH-¿£µµ¸£ÇÉ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • peak
    ÃÖ°íÁ¡, Á¤
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â
  • peak intensity
    ÃÖ°í°­µµ, ÃÖ°í¼¼±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
PRO-PBP pro-platelet basic protein
CGA catabolite gene activator; color graphics adapter
misc miscarriage; miscellaneous
PIP paralytic infantile paralysis; peak inflation pressure, peak inspiratory pressure; periodic interim ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Pro-UK Pro-Urokinase
pro-NPY Pro-neuropeptide Y
pro-TRH Pro-thyrotrophin-releasing hormone
pro-CCK pro-cholecystokinin
pro-enk pro-enkephalin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adapter
    ¿¬°á±â, ¿¬°á±â°ü, ÀûÀÀ±â, ¾Æ´ðÅÍ, Á¢ÇÕ±â, À¯µµ°ü
    µ¿ÀǾî=ada
  • pro
    Àü±¸
    ¾Õ, Àü¹æÀÇ ¶æÀ» ³ªÅ¸³»´Â Á¢µÎ¾î.
  • DNA absorption peak
    ÃÖ°í DNA Èí¼ö
  • peak
    Á¤Á¡, ÃÖ°íÁ¡, Á¤
  • peak expiratory flow
    ÃÖ´ë È£±â À¯·®
  • peak flow rate
    ÃÖ´ë À¯¼Ó, ÃÖ°í À¯¼Ó
  • peak height velocity
    ½ÅÀåÀÇ ÃÖ´ë Áõ°¡, ÃÖ´ë Áõ°¡·® °î¼±
  • peak metabolism
    Á¤´ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adapter 1. One who adapts.
2. <chemistry> A connecting tube; an adopter.
Source: Websters Dictionary
(01 Mar 1998)
biclonal peak Two narrow electrophoretic bands thought to represent immunoglobulin of two cell lines.
(05 Mar 2000)
peak The top or upper limit of a graphic tracing or of any variable.
Origin: M.E. Peke, pike, fr. Sp. Pico, beak, fr. L. Picus, magpie
(05 Mar 2000)
peak expiratory flow The maximum flow at the outset of forced expiration, which is reduced in proportion to the severity of airway obstruction, as in asthma.
(05 Mar 2000)
peak expiratory flow rate Measurement of the maximum rate of airflow attained during a forced vital capacity determination. Common abbreviations are pefr and pfr.
(12 Dec 1998)
peak flow <chest medicine, physiology> The maximum flow rate of air breathed out during forced expiration.
(15 Nov 1997)
peak flow rate Maximum urinary flow rate during voiding as measured by a uroflowmeter.
(05 Mar 2000)
peak magnitude The greatest amplitude.
(05 Mar 2000)
peak plasma drug concentration <pharmacology> The highest level of drug that can be obtained in the blood usually following multiple doses.
(09 Oct 1997)
monoclonal peak A narrow band visible on electrophoresis or an abnormal arc seen on immunoelectrophoresis, thought to represent immunoglobulin of one cell clone.
(05 Mar 2000)
widow's peak A sharp point of hair growth in the midline of the anterior scalp margin, usually resulting from recession of hair of the temple areas, or occurring as a congenital configuration of scalp hair.
(05 Mar 2000)
juxtaphrenic peak On chest radiograph, a triangular density on top of the right diaphragmatic shadow, probably caused by tension of the phrenic nerve on the pleura over the diaphragm.
(05 Mar 2000)
ATP citrate (pro-3S)-lyase <enzyme> An enzyme that, in the presence of ATP and CoA, catalyses the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and orthophosphate. This reaction represents an important step in fatty acid biosynthesis.
Chemical name: ATP:citrate oxaloacetate-lyase ((pro-S)-CH2COO(-)--acetyl-CoA) (ATP-dephosphorylating)
Registry number: EC 4.1.3.8
Synonym: citrate cleavage enzyme.
(12 Dec 1998)
RNA, transfer, pro A transfer RNA which is specific for carrying proline to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
citrate (pro-3S)-lyase <enzyme> Consists of two enzymes and an acyl carrier protein
Registry number: EC 4.1.3.6
Synonym: citrate lyase
(26 Jun 1999)
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 1 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adapter
    °¢»öÀÚ
  • adapter
    °¢»öÀÚ;°¡°¨ÀåÄ¡;¾î´ðÅÍ
  • docking adapter
    µµÅ·ÇÑ µÎ ¿ìÁÖ¼±ÀÇ ¿¬°áÅë·Î
  • peak
    ÷´Ü
  • peak
    ºÀ¿ì¸®;»ê²À´ë±â;÷´Ü;ÃÖ°íÁ¡;ì;»ÏÁ·ÇÑ
  • peak experience
    Áö°í üÇè;°è½Ã
  • peak fresh
    Á¦Ã¶ÀÇ;ÇÑâ¶§ÀÇ
  • peak hour
    ÃÖ°í½Ã;°ñµç ¾Æ¿ö
  • peak load
    ÇDZ×(ÀýÁ¤)ºÎÇÏ;ÀýÁ¤ ÇÏÁß
  • widow's peak
    À̸¶ Áß¾Ó¿¡ vÀÚÇüÀ¸·Î ³­ ¸Ó¸®
  • pro
    ÇÁ·Î
  • pro-
    ´ë½Å
  • Pro. Station
    ¼ºº´ ¿¹¹æ½Ã¼³
  • per pro
    per procurationem
  • pro
    ÇÁ·Î;Àü¹®°¡;Á÷¾÷¼±¼ö;Á÷¾÷ÀûÀÎ;Á÷¾÷¼±¼öÀÇ;ÇÁ·ÎÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á